Emcure Pharmaceuticals Ltd Share Price
₹1449.80
+87.40
(+6.42%)
as on
🔔 Partnership Alert
Emcure Pharmaceuticals partners with Novo Nordisk to exclusively distribute and market Poviztra, a weight-loss injection, expanding access across India.
Emcure Pharmaceuticals Ltd Stock Performance
as on November 10, 2025 at 1:03 pm IST
Day's Low
Day's High
₹1,362.4₹1,463.7
6.03%
Downside
0.96%
Upside
52 Week's Low
52 Week's High
₹889₹1,52538.68%
Downside
5.19%
Upside
Emcure Pharmaceuticals Ltd share price movements today
- Previous Close
- ₹1,362.40
- Open
- ₹1,450.00
- Volume
- 6.25L
- Upper Circuit
- ₹1,498.60
- Lower Circuit
- ₹1,226.20
- Day's Low - High
- ₹1,362.4 - ₹1,463.7
- 52 Week Low - High
- ₹889 - ₹1,525
Emcure Pharmaceuticals Ltd Historical Returns
- 1 Month Return
- -4.27 %
- 3 Month Return
- -1.98 %
- 1 Year Return
- -5.02 %
- 3 Year Return
- + 0.24 %
- 5 Year Return
- + 0.24 %
Emcure Pharmaceuticals Ltd Fundamentals
as on November 10, 2025 at 1:03 pm IST
Market Cap
₹25,826.31 Cr
Return on Equity (ROE)
12.79
PE Ratio (TTM)
34.72
Return on capital employed (ROCE)
14.36
Industry PE ratio
41.8
Beta (LTM)
1.25
P/B Ratio
6.72
Dividend Yield
0.28
PEG Ratio
3.17
Quarterly Earnings Growth YOY
40.76
EPS (TTM)
37.34
Sector
Pharmaceuticals
Book Value
234.65
Technical Analysis
Bullish
View Technical Analysis
Emcure Pharmaceuticals Ltd Stock Valuation
as on November 10, 2025 at 1:03 pm IST
Emcure Pharmaceuticals Ltd in the last 5 years
Lowest (24.97x)
April 9, 2025
Today (34.72x)
November 7, 2025
Industry (41.80x)
November 7, 2025
Highest (53.98x)
September 18, 2024
Today’s Price to Earnings Ratio: 34.72x
Emcure Pharmaceuticals Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Emcure Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 25,826.31 | 0.05% | 0.63 | 707 | 7,896 | |
| NA | 9.28 | -8.62% | 0.00 | -1 | 2 | |
| NA | 3.63 | 2.89% | 0.00 | -1 | NA | |
| BUY | 10,375.83 | 8.94% | 0.00 | 135 | 498 | |
| NA | 335.74 | 91% | 0.64 | 7 | 138 |
Analyst Recommendation on Emcure Pharmaceuticals Ltd Stock
Based on 6 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 6 analysts, 83.33% of analysts recommend a 'BUY' rating for Emcure Pharmaceuticals Ltd. Average target price of ₹1631.67
Source: S&P Global Market Intelligence
Emcure Pharmaceuticals Ltd Share Price Target
Get share price movements and forecasts by analysts on Emcure Pharmaceuticals Ltd.
What analysts predicted
19.76%UPSIDE
Target Price
₹1631.67
Current Price
₹1449.8
Analyzed by
6 Analysts
High
₹1740
Target
₹1631.67
Low
₹1530
Emcure Pharmaceuticals Ltd target price ₹1631.67, a slight upside of 19.76% compared to current price of ₹1449.8. According to 6 analysts rating.
Source: S&P Global Market Intelligence
Emcure Pharmaceuticals Ltd Stock’s Investor Sentiment and Interest
Search interest for Emcure Pharmaceuticals Ltd Stock has increased by 4% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:4% versus previous 30 day period
Emcure Pharmaceuticals Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Emcure Pharmaceuticals Ltd Annual Profit & Loss
Figures in Rupees Crores
Emcure Pharmaceuticals Ltd Cash Flow
Figures in Rupees Crores
Emcure Pharmaceuticals Ltd Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Emcure Pharmaceuticals Ltd Stock
Check out the Mutual Funds with significant holdings in Emcure Pharmaceuticals Ltd.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 Aditya Birla Sun Life ELSS Tax Saver Direct Plan Growth | 0.89% | 1055602 | |
 Nippon India Multi Cap Fund - Direct Plan - Growth | 0.27% | 1000000 | |
 DSP Aggressive Hybrid Fund Direct Plan Growth | 0.54% | 483926 | |
Nippon India Pharma Fund - Direct Plan - Growth Plan | 0.74% | 470272 | |
 ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth | 0.92% | 445701 |
Emcure Pharmaceuticals Ltd Corporate Actions
View detailed summary of the earnings and dividend history of Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd Earnings Results
Emcure Pharmaceuticals Ltd’s net profit jumped 43.64% since last year same period to ₹206.95Cr in the Q1 2025-2026. On a quarterly growth basis, Emcure Pharmaceuticals Ltd has generated 9.52% jump in its net profits since last 3-months.
Read More about Earnings ResultsEmcure Pharmaceuticals Ltd Dividends May,2025
In the quarter ending March 2025, Emcure Pharmaceuticals Ltd has declared dividend of ₹3.00 per share on 22 May 2025 - translating a dividend yield of 0.22%.
Read More about Dividends
Emcure Pharmaceuticals Ltd News & Key Events
Today's Timeline - 10 November
11:27 AM
-Emcure Pharmaceuticals partners with Novo Nordisk to launch Poviztra, a weight-loss injection, as exclusive distributor in India.
11:56 AM
-Emcure shares rise 7% to 1455 rupees following the partnership announcement with Novo Nordisk for Poviztra distribution.
Indices Featuring Emcure Pharmaceuticals Ltd Stock
Check stock indices that include Emcure Pharmaceuticals Ltd.
Insights on Emcure Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTFII Holding Up
Foreign Institutions have increased holdings from 2.86% to 3.29% in Sep 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, EMCURE stock has moved up by 3.0%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 2.34% to 3.58% in Sep 2025 quarter
NEGATIVE IMPACTPromoter Holding Down
Promoters have decreased holdings from 77.91% to 77.88% in Sep 2025 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 16.39% to 14.46% in Sep 2025 quarter
About Emcure Pharmaceuticals Ltd
Revenue: ₹2,100.54Cr as on June 2025 (Q1 FY26)
Net Profit: ₹214.79Cr as on June 2025 (Q1 FY26)
Listing date: 10 Jul, 2024
| Organisation | Emcure Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs
What is Emcure Pharmaceuticals Ltd share price today?
Emcure Pharmaceuticals Ltd share price today stands at ₹1449.8 as on . Emcure Pharmaceuticals Ltd share today touched a day high of ₹1463.7 and a low of ₹1362.4.
What is the 52 week high and 52 week low range for Emcure Pharmaceuticals Ltd share?
Emcure Pharmaceuticals Ltd touched a 52 week high of ₹1525 and a 52 week low of ₹889. Emcure Pharmaceuticals Ltd share price today i.e. is trending at ₹1449.8, which is -4.93% down from its 52 week high and 63.08% up from its 52 week low.
What is Emcure Pharmaceuticals Ltd's market capitalisation today?
Emcure Pharmaceuticals Ltd market capitalisation is ₹25,826.31 Cr as on .
How to buy Emcure Pharmaceuticals Ltd shares?
To buy Emcure Pharmaceuticals Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for EMCURE or Emcure Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Emcure Pharmaceuticals Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Emcure Pharmaceuticals Ltd trading volume today?
Emcure Pharmaceuticals Ltd trading volume is 6.25L as on . This means that 6.25L shares of Emcure Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.